{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:06:51Z","timestamp":1789654011398,"version":"4.0.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Describe the epidemiology of patients with cirrhosis\/acute-on-chronic liver failure (ACLF) receiving continuous renal replacement therapy (CRRT) pertaining to process factors including renal replacement dose, modality, and circuit anticoagulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Academic tertiary care hospitals in the United States and Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and Patients:<\/jats:title>\n                    <jats:p>We performed a parallel study of contemporaneous data from the HARMONY and CRRT network (CRRTnet) databases to describe the epidemiology and process of CRRT care of cirrhosis\/ACLF patients receiving CRRT in the ICU. We evaluated clinical and CRRT process factors (dialysis dose, anticoagulation) with the primary outcome of in-hospital mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      The HARMONY cohort (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 245; median age, 57 yr; 41% female) and CRRTnet cohort (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 206; 58 yr; 39% female) demonstrated similar overall survival to hospital discharge (HARMONY, 34%; CRRTnet, 30%). In HARMONY, the two most common causes of acute kidney injury (AKI) requiring CRRT were acute tubular necrosis (73%) and hepatorenal syndrome-AKI (13%), with no significant difference between survivors and nonsurvivors (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.24). In HARMONY, higher chronic liver failure-C ACLF scores (hazard ratio, 1.03 [95% CI, 1.01\u20131.05];\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001) were independently associated with increased in-hospital mortality. In CRRTnet, the most common CRRT modality was continuous venovenous hemodiafiltration (83.8%), and the most common anticoagulation strategy was regional citrate anticoagulation (58.0%) or no anticoagulation (35.8%). CRRT prescribed dose greater than 30\u2009mL\/kg\/hr was independently associated with higher in-hospital mortality (multivariable regression; odds ratio, 2.69; 95% CI, 1.3\u20135.64;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.01). Of survivors in CRRTnet, 64% were transitioned to intermittent hemodialysis (IHD) before hospital discharge.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Critically ill cirrhosis\/ACLF patients initiated on CRRT in the absence of liver transplantation had high in-hospital mortality. These patients were prescribed higher initial CRRT doses (median total effluent &gt; 30\u2009mL\/kg\/hr), with higher CRRT dose independently associated with increased in-hospital mortality. Of ICU survivors, 64% were transitioned to IHD at ICU discharge. Despite concerns for citrate toxicity, citrate regional anticoagulation was commonly employed in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000007363","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:00:08Z","timestamp":1789653608000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology of Critically Ill Patients With Cirrhosis Undergoing Continuous Renal Replacement Therapy: A Contemporaneous Parallel Analysis of the HRS-HARMONY and CRRTnet Registries"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1555-1089","authenticated-orcid":false,"given":"Constantine J.","family":"Karvellas","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, Canada."},{"name":"Division of Gastroenterology (Liver Unit), Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Lambert","sequence":"additional","affiliation":[{"name":"College of Nursing, University of Cincinnati, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Bagshaw","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cullaro","sequence":"additional","affiliation":[{"name":"Center for Liver Disease and Transplantation, Columbia University Vagelos College of Physicians and Surgeons, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Fricker","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Frederick","sequence":"additional","affiliation":[{"name":"Division of Hepatology, Department of Advanced Organ Therapies and Transplantation, California Pacific Medical Center, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"House","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Western University, London, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Juncos","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Arkansas, Little Rock, AR."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heung","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavish R.","family":"Patidar","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Sherrie and Alan Conover Center for Liver Disease and Transplantation, J.C. Walter Jr Transplant Center, Houston Methodist Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksa G.","family":"Rewa","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jevon E.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Pedro","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Divisions of Nephrology and Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of New Mexico, Albuquerque, NM."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Wadei","sequence":"additional","affiliation":[{"name":"Department of Transplant, Mayo Clinic, Jacksonville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier A.","family":"Neyra","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Allegretti","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CRRTnet and HRS-HARMONY Consortia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"R1-20260917","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites.","volume":"62","author":"Angeli","year":"2015","journal-title":"J Hepatol"},{"key":"R2-20260917","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"R3-20260917","doi-asserted-by":"crossref","first-page":"100270","DOI":"10.1016\/j.aohep.2020.09.014","article-title":"Renal and brain failure predict mortality of patients with acute-on-chronic liver failure admitted to the intensive care unit.","volume":"22","author":"Mendez-Guerrero","year":"2021","journal-title":"Ann Hepatol"},{"key":"R4-20260917","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jhep.2017.07.008","article-title":"Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis.","volume":"67","author":"Piano","year":"2017","journal-title":"J Hepatol"},{"key":"R5-20260917","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.14309\/ajg.0000000000000771","article-title":"The use of NACSELD and EASL-CLIF classification systems of ACLF in the prediction of prognosis in hospitalized patients with cirrhosis.","volume":"115","author":"Cao","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"R6-20260917","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document.","volume":"71","author":"Angeli","year":"2019","journal-title":"J Hepatol"},{"key":"R7-20260917","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2024.03.031","article-title":"Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting.","volume":"81","author":"Nadim","year":"2024","journal-title":"J Hepatol"},{"key":"R8-20260917","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc11188","article-title":"Hepatorenal syndrome: The 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.","volume":"16","author":"Nadim","year":"2012","journal-title":"Crit Care"},{"key":"R9-20260917","doi-asserted-by":"crossref","first-page":"687","DOI":"10.23876\/j.krcp.21.033","article-title":"Clinical outcomes and prognostic factors of mortality in liver cirrhosis patients on continuous renal replacement therapy in two tertiary hospitals in Korea.","volume":"40","author":"Jeon","year":"2021","journal-title":"Kidney Res Clin Pract"},{"key":"R10-20260917","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/HEP.0000000000000671","article-title":"AASLD practice guidance on acute-on-chronic liver failure and the management of critically ill patients with cirrhosis.","volume":"79","author":"Karvellas","year":"2024","journal-title":"Hepatology"},{"key":"R11-20260917","doi-asserted-by":"crossref","first-page":"192","DOI":"10.34067\/KID.0005342020","article-title":"Regional citrate anticoagulation protocol for patients with presumed absent citrate metabolism.","volume":"2","author":"Szamosfalvi","year":"2021","journal-title":"Kidney360"},{"key":"R12-20260917","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/sdi.12224","article-title":"Is there a role for dialysis in patients with hepatorenal syndrome who are not liver transplant candidates?","volume":"27","author":"Belcher","year":"2014","journal-title":"Semin Dial"},{"key":"R13-20260917","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2215\/CJN.03610417","article-title":"Prognosis of patients with cirrhosis and AKI who initiate RRT.","volume":"13","author":"Allegretti","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R14-20260917","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis.","volume":"59","author":"Fagundes","year":"2013","journal-title":"J Hepatol"},{"key":"R15-20260917","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.jhep.2023.07.010","article-title":"Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US.","volume":"79","author":"Patidar","year":"2023","journal-title":"J Hepatol"},{"key":"R16-20260917","doi-asserted-by":"crossref","first-page":"247","DOI":"10.34067\/KID.0000000589","article-title":"Association of hepatorenal syndrome-acute kidney injury with mortality in patients with cirrhosis requiring renal replacement therapy: Results from the HRS-HARMONY Consortium.","volume":"6","author":"Cama-Olivares","year":"2025","journal-title":"Kidney360"},{"key":"R17-20260917","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12882-017-0650-2","article-title":"CRRTnet: A prospective, multi-national, observational study of continuous renal replacement therapy practices.","volume":"18","author":"Heung","year":"2017","journal-title":"BMC Nephrol"},{"key":"R18-20260917","doi-asserted-by":"crossref","first-page":"100641","DOI":"10.1016\/j.xkme.2023.100641","article-title":"Epidemiology and outcomes of AKI treated with continuous kidney replacement therapy: The Multicenter CRRTnet Study.","volume":"5","author":"Rewa","year":"2023","journal-title":"Kidney Med"},{"key":"R19-20260917","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000512846","article-title":"Dose of continuous renal replacement therapy in critically ill patients: A bona fide quality indicator.","volume":"145","author":"Vasquez Jimenez","year":"2021","journal-title":"Nephron"},{"key":"R20-20260917","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data.","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"key":"R22-20260917","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1007\/s10620-024-08623-2","article-title":"Prognosis of transplant-ineligible patients with cirrhosis and acute kidney injury who initiate renal replacement therapy.","volume":"69","author":"Diaz","year":"2024","journal-title":"Dig Dis Sci"},{"key":"R23-20260917","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/j.ajkd.2019.06.013","article-title":"Continuous renal replacement therapy dosing in critically ill patients: A quality improvement initiative.","volume":"74","author":"Griffin","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"R24-20260917","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"R25-20260917","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1097\/01.CCM.0000084871.76568.E6","article-title":"Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients.","volume":"31","author":"Kramer","year":"2003","journal-title":"Crit Care Med"},{"key":"R26-20260917","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2020.18618","article-title":"Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: A randomized clinical trial.","volume":"324","author":"Zarbock","year":"2020","journal-title":"JAMA"},{"key":"R27-20260917","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MEG.0000000000002630","article-title":"A combination of clot formation abnormalities in thromboelastometry has a high prognostic value in patients with acute-on-chronic liver failure.","volume":"36","author":"Kampelos","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R28-20260917","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa2000741","article-title":"Timing of initiation of renal-replacement therapy in acute kidney injury.","volume":"383","author":"Bagshaw","year":"2020","journal-title":"N Engl J Med"},{"key":"R29-20260917","first-page":"S1987","article-title":"Initiation of renal replacement therapy in critically-ill patients with cirrhosis\/chronic liver disease: A secondary analysis of STARRT-AKI trial.","volume":"80","author":"Karvellas","year":"2024","journal-title":"Hepatology"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:00:12Z","timestamp":1789653612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":28,"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007363","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}